Technical Analysis for CLIN - Clinigen Group Plc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 618.5 | -0.72% | -4.50 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Historical CLIN trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | -0.72% | |
| Wide Bands | Range Expansion | -0.72% | |
| Wide Bands | Range Expansion | -1.51% | |
| 1,2,3 Retracement Bearish | Bearish Swing Setup | -2.90% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 10 DMA Support | 2 days ago |
| Fell Below Previous Day's Low | 2 days ago |
| Down 2% | 2 days ago |
| Down 1% | 2 days ago |
| Fell Below 10 DMA | 2 days ago |
Free Daily (Stock) Chart Reading
Clinigen Group Plc Description
Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.
Classification
Sector: Healthcare
Industry: Medical Distribution
Keywords: Health Healthcare Pharmaceutical Consultancy Biotechnology Medicine Clinic Pharmaceuticals Hospital Drugs Clinical Trial Pharmaceutical Industry Therapies Rescue Clinical Research Pharmaceutical Products Medication Pharmaceutical Industry In China Pharmaceuticals Policy Design Of Experiments Medical Products Pharmaceutical Companies Idis Clinical Trial Services
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 891.79 |
| 52 Week Low | 554.0 |
| Average Volume | 875,558 |
| 200-Day Moving Average | 713.87 |
| 50-Day Moving Average | 786.60 |
| 20-Day Moving Average | 711.18 |
| 10-Day Moving Average | 625.85 |
| Average True Range | 32.44 |
| ADX | 33.39 |
| +DI | 15.51 |
| -DI | 35.83 |
| Chandelier Exit (Long, 3 ATRs) | 794.46 |
| Chandelier Exit (Short, 3 ATRs) | 657.14 |
| Upper Bollinger Bands | 932.94 |
| Lower Bollinger Band | 489.41 |
| Percent B (%b) | 0.29 |
| BandWidth | 62.37 |
| MACD Line | -54.47 |
| MACD Signal Line | -49.35 |
| MACD Histogram | -5.1237 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 636.50 | ||||
| Resistance 3 (R3) | 638.50 | 634.50 | 633.50 | ||
| Resistance 2 (R2) | 634.50 | 629.92 | 633.50 | 632.50 | |
| Resistance 1 (R1) | 626.50 | 627.08 | 624.50 | 624.50 | 631.50 |
| Pivot Point | 622.50 | 622.50 | 621.50 | 621.50 | 622.50 |
| Support 1 (S1) | 614.50 | 617.92 | 612.50 | 612.50 | 605.50 |
| Support 2 (S2) | 610.50 | 615.08 | 609.50 | 604.50 | |
| Support 3 (S3) | 602.50 | 610.50 | 603.50 | ||
| Support 4 (S4) | 600.50 |
